Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für molekulare Genetik     Collection: Research Group Development and Disease     Display Documents



  history
ID: 334867.0, MPI für molekulare Genetik / Research Group Development and Disease
Multiple roles for neurofibromin in skeletal development and growth.
Authors:Kolanczyk, Mateusz; Kossler, Nadine; Kühnisch, Jirko; Lavitas, Liron; Stricker, Sigmar; Wilkening, Ulrich; Manjubala, Inderchand; Fratzl, Peter; Spörle, Ralf; Herrmann, Bernhard G.; Parada, Luis F.; Kornak, Uwe; Mundlos, Stefan
Language:English
Date of Publication (YYYY-MM-DD):2007-02-22
Title of Journal:Human Molecular Genetics
Journal Abbrev.:Hum Mol Genet.
Volume:16
Issue / Number:8
Start Page:232
End Page:240
Copyright:© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Review Status:not specified
Audience:Experts Only
Abstract / Description:Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder primarily characterized by the formation of neurofibromas, café-au-lait spots and freckling. Skeletal abnormalities such as short stature or bowing/pseudarthrosis of the tibia are relatively common. To investigate the role of the neurofibromin in skeletal development, we crossed Nf1flox mice with Prx1Cre mice to inactivate Nf1 in undifferentiated mesenchymal cells of the developing limbs. Similar to NF1 affected individuals, Nf1Prx1 mice show bowing of the tibia and diminished growth. Tibial bowing is caused by decreased stability of the cortical bone due to a high degree of porosity, decreased stiffness and reduction in the mineral content as well as hyperosteoidosis. Accordingly, osteoblasts show an increase in proliferation and a decreased ability to differentiate and mineralize in vitro. The reduction in growth is due to lower proliferation rates and a differentiation defect of chondrocytes. Abnormal vascularization of skeletal tissues is likely to contribute to this pathology as it exerts a negative effect on cortical bone stability. Furthermore, Nf1 has an important role in the development of joints, as shown by fusion of the hip joints and other joint abnormalities, which are not observed in neurofibromatosis type I. Thus, neurofibromin has multiple essential roles in skeletal development and growth.
Comment of the Author/Creator:To whom correspondence should be addresssed. Email: mundlos@molgen.mpg.de
External Publication Status:published
Document Type:Article
Version Comment:Automatic journal name synchronization
Communicated by:Stefan Mundlos
Affiliations:MPI für Kolloid- und Grenzflächenforschung/Biomaterialien
External Affiliations:1.Institute for Medical Genetics, Charitè, Universitätsmedizin Berlin, Germany;
2.Institut für Medizinische Genetik, CBF, Charité, Berlin, Germany;
3.University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Identifiers:ISSN:0964-6906
DOI:10.1093/hmg/ddm032
URL:http://hmg.oxfordjournals.org/cgi/reprint/16/8/874...
Full Text:
You have privileges to view the following file(s):
874.pdf  [1,00 Mb]   
 
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.